News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Vetter’s Development Service Doubles its Revenues and Grows its Capabilities


9/27/2012 10:20:08 AM

CHICAGO & RAVENSBURG, Germany--(BUSINESS WIRE)--Vetter, a leading contract development and manufacturing organization (CDMO), reports that its Development Service doubled its revenues over the last five years, due to increased customer demand for support on complex biologics. Vetter Development Service (VDS) supports products from preclinical development through Phase III and develops robust processes that enable a seamless transfer to Vetter Commercial Manufacturing. Offering a continuum of service, the global VDS organization comprises more than 150 scientists, engineers and other personnel. Vetter’s Chicago facility provides early-stage clinical production, featuring equipment optimized for small-batch manufacturing. Ravensburg facilities support a range of development products through Phase III and feature sophisticated new technologies with enhanced analytical capabilities.

Read at BioSpace.com


comments powered by Disqus
Vetter
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES